Mupider Nasale (Mupirocin)

Mupirocin, the active ingredient in Mupider Nasale, is an antibiotic presented as a nasal spray for nasal use. It treats bacterial colonisation and infection of the nasal passages, particularly targeting Staphylococcus aureus in patients at risk of transmission or postoperative infection.

GNH USA supplies Mupider Nasale as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Mupider Nasale is an antibacterial agent applied to the nasal mucosa to eradicate pathogenic bacteria. - Nasal carriage of Staphylococcus aureus: reduces bacterial load and helps prevent subsequent infection. - Pre‑surgical decolonisation: lowers the risk of postoperative surgical‑site infections. - Bacterial rhinosinusitis: alleviates symptoms by eliminating the causative organisms.

Mupider Nasale may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation. - Stinging or mild pain at the application site. - Nasal dryness or crusting. - Sneezing or transient rhinorrhoea. - Headache.

Serious or Rare Side Effects: - Allergic reactions including anaphylaxis. - Contact dermatitis or severe skin eruption. - Nasal septum perforation with prolonged use. - Secondary infection with resistant organisms. - Systemic hypersensitivity reactions such as fever or malaise.

Before using Mupider Nasale, consider the following safety measures. - Pregnancy: safety not established; use only if clearly needed. - Breastfeeding: limited data; weigh potential risks against benefits. - Allergy: avoid if known hypersensitivity to mupirocin or related antibiotics. - Local irritation: monitor for severe burning, ulceration, or persistent discomfort. - Extensive mucosal application: systemic absorption is unlikely but caution is advised in large‑area use. - Store at room temperature: keep in the original container, protect from moisture and light.

Mupider Nasale has a limited interaction profile, but certain combinations require attention.

Major Interactions (Avoid): - Concurrent use with other topical antibiotics: may increase risk of local irritation or bacterial resistance. - Use with systemic immunosuppressants: may reduce overall infection control effectiveness.

Moderate Interactions (Monitor Closely): - Co‑administration with antifungal nasal agents: monitor for additive mucosal irritation. - Simultaneous use of nasal decongestants: observe for altered drug distribution. - Application together with corticosteroid nasal sprays: assess for potential changes in local healing response.